Applied Therapeutics Inc (NASDAQ: APLT) started the day on Wednesday, with a price decrease of -9.90% at $8.92, before settling in for the price of $9.90 at the close. Taking a more long-term approach, APLT posted a 52-week range of $1.79-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -8.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.49%. This publicly-traded company’s shares outstanding now amounts to $116.36 million, simultaneously with a float of $87.13 million. The organization now has a market capitalization sitting at $1.04 billion. At the time of writing, stock’s 50-day Moving Average stood at $8.06, while the 200-day Moving Average is $5.89.
Applied Therapeutics Inc (APLT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Applied Therapeutics Inc’s current insider ownership accounts for 25.12%, in contrast to 80.82% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’24, this organization’s Chief Financial Officer sold 13,530 shares at the rate of 5.83, making the entire transaction reach 78,880 in total value, affecting insider ownership by 277,911. Preceding that transaction, on Aug 22 ’24, Company’s Chief Medical Officer sold 22,681 for 5.83, making the whole transaction’s value amount to 132,230. This particular insider is now the holder of 986,853 in total.
Applied Therapeutics Inc (APLT) Earnings and Revenue Records
Applied Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 12.49% and is forecasted to reach -0.48 in the upcoming year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Therapeutics Inc (APLT). It’s Quick Ratio in the last reported quarter now stands at 1.06. The Stock has managed to achieve an average true range (ATR) of 0.63. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 97.36.
In the same vein, APLT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.32, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.48 at the market close of one year from today.
Technical Analysis of Applied Therapeutics Inc (APLT)
If we take a close look at the recent performances of Applied Therapeutics Inc (NASDAQ: APLT), its last 5-days Average volume was 1.98 million that shows progress from its year to date volume of 1.83 million. During the previous 9 days, stock’s Stochastic %D was recorded 53.22% While, its Average True Range was 0.65.
Raw Stochastic average of Applied Therapeutics Inc (APLT) in the period of the previous 100 days is set at 73.48%, which indicates a major rise in contrast to 25.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.34% that was lower than 105.79% volatility it exhibited in the past 100-days period.
